Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHWANDT, P")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 159

  • Page / 7
Export

Selection :

  • and

NEBENWIRKUNGEN UND ARNEIMITTELWECHSELWIRKUNGEN LIPIDSENKENDER PHARMAKA = EFFETS SECONDAIRES ET INTERACTIONS MEDICAMENTEUSES DES DROGUES HYPOLIPEMIANTESSCHWANDT P.1980; MUENCH. MED. WSCHR.; DEU; DA. 1980; VOL. 122; NO 13; PP. 474-476; BIBL. 69 REF.Article

SPECIAL LIPID MOBILIZING HORMONES FROM THE PITUITARY GLAND (LIPOTROPINS)SCHWANDT P.1973; ACTA ENDOCRINOL., SUPPL.; DANEM.; DA. 1973; NO 173; PP. 177-178; RESUMEArticle

DRUG INTERACTIONS AND SIDE EFFECTS OF HYPOLIPIDEMIC DRUGSSCHWANDT P.1979; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1979; VOL. 17; NO 8; PP. 351-356; BIBL. 2 P.Article

PITUITARY LIPOLYTIC PEPTIDESSCHWANDT P.1979; ANN. NUTRIT. ALIMENT.; FRA; DA. 1979; VOL. 33; NO 1; PP. 39-56; BIBL. 2 P.Article

PROBLEMS IN TESTING HYPOLIPIDEMIC AGENTS IN PHASE IISCHWANDT P.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 8; PP. 370-373; BIBL. 8 REF.Article

THERAPIE DER HYPERLIPOPROTEINAEMIEN = TRAITEMENT DES HYPERLIPOPROTEINEMIESSCHWANDT P.1980; MED. WELT; DEU; DA. 1980; VOL. 31; NO 24; PP. 905-906Article

WECHSELWIRKUNGEN BEI BEHANDLUNG MIT HYPOLIPIDAEMIKA UND URIKOSTATIKA. = INTERACTIONS DANS LE TRAITEMENT PAR HYPOLIPEMIANTS ET URICOSTATIQUESSCHWANDT P.1978; THERAPIEWOCHE; DTSCH.; DA. 1978; VOL. 28; NO 16; PP. 3182-3184; BIBL. 8 REF.Article

Fibrates and triglyceride metabolismSCHWANDT, P.European journal of clinical pharmacology. 1991, Vol 40, pp S41-S43, issn 0031-6970, SUP1Conference Paper

Hypothalamic control of lipid metabolismSCHWANDT, P.Acta neurochirurgica. 1985, Vol 75, Num 1-4, pp 122-124, issn 0001-6268Article

EFFECTS OF ETIROXATE ON LOW DENSITY AND HIGH DENSITY LIPOPROTEINS IN HYPERCHOLESTEROLEMIC PATIENTSWEISWEILER P; SCHWANDT P.1981; ATHEROSCLEROSIS; ISSN 0021-9150; NLD; DA. 1981; VOL. 39; NO 1; PP. 45-49; BIBL. 16 REF.Article

HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS AFTER A SHORT TERM FASTSCHWANDT P; WEISWEILER P.1981; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1981; VOL. 13; NO 8; PP. 467-468; BIBL. 9 REF.Article

BEHANDLUNG DER PRIMAREN HYPERLIPOPROTEINAMIE TYP IV MIT VERS-CHIEDENEN BIGUANIDEN = TRAITEMENT DE L'HYPERLIPOPROTEINEMIE TYPE IV PRIMITIVE AU MOYEN DE DIVERS BIGUANIDESWEISWEILER P; SCHWANDT P.1976; KLIN. WSCHR.; DTSCH.; DA. 1976; VOL. 54; NO 6; PP. 283-285; ABS. ANGL.; BIBL. 18 REF.Article

LIPOPROTEIN AND APOLIPOPROTEIN CHANGES IN OBESITY AFTER A SHORT-TERM FASTWEISWEILER P; SCHWANDT P.1981; INT. J. OBESITY; GBR; DA. 1981; VOL. 5; NO 1; PP. 11-14; BIBL. 18 REF.Article

The importance of reaching lipid targets: Statins and the prevention of atherosclerosisSCHWANDT, P.International journal of clinical practice (Esher). 2003, Vol 57, Num 5, pp 396-404, issn 1368-5031, 9 p.Article

POSTMORTAL DEGRADATION OF NEUROPEPTIDES IN THE NEUROHYPOPHYSISRICHTER WO; SCHWANDT P.1983; NEUROPEPTIDES (EDINBURGH); ISSN 0143-4179; GBR; DA. 1983; VOL. 3; NO 5; PP. 379-386; BIBL. 9 REF.Article

LIPOPROTEIN LIPIDS AND APOLIPOPROTEINS AFTER SIX MONTHS' TREATMENT WITH BEZAFIBRATEWEISWEILER P; SCHWANDT P.1980; ARTERY; USA; DA. 1980; VOL. 6; NO 4; PP. 402-408; BIBL. 17 REF.Article

UNIQUENESS IN THE RADIAL DEPENDENCE OF THE OPTICAL POTENTIAL FOR ALPHA-NUCLEUS SCATTERINGSINGH PP; SCHWANDT P.1972; PHYS. LETTERS, B; NETHERL.; DA. 1972; VOL. 42; NO 2; PP. 181-185; BIBL. 16 REF.Serial Issue

Triglyceride-rich lipoproteins and atherosclerosisSCHWANDT, P.Drugs (Basel). 1990, Vol 40, pp 38-41, issn 0012-6667, 4 p., Suppl. 1Conference Paper

Fat modified diet in the prevention of cardiovascular disease. Recommendations and guidelinesSCHWANDT, P.Acta cardiologica. 1989, Vol 44, Num 6, pp 490-492, issn 0001-5385, 3 p.Conference Paper

PURIFICATION OF PORCINE NEUROPHYSINS I AND II BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYSCHWANDT P; RICHTER WO.1980; BIOCHIM. BIOPHYS. ACTA; ISSN 0006-3002; NLD; DA. 1980; VOL. 626; NO 2; PP. 376-382; BIBL. 24 REF.Article

CHRONISCHE INSULINUEBERBEHANDLUNG BEI DIABETIKERN IM ERWACHSENENALTER = SURDOSAGE CHRONIQUE EN INSULINE CHEZ DES DIABETIQUES ADULTESSCHWANDT P; RICHTER W.1980; DTSCH. MED. WSCHR.; DEU; DA. 1980; VOL. 105; NO 25; PP. 892-894; ABS. ENG; BIBL. 12 REF.Article

THE EFFECT OF D-THYROXINE ON LIPOPROTEIN LIPIDS AND APOLIPOPROTEINS IN PRIMARY TYPE IIA HYPERLIPOPROTEINEMIASCHWANDT P; WEISWEILER P.1980; ATHEROSCLEROSIS; NLD; DA. 1980; VOL. 35; NO 3; PP. 301-306; BIBL. 16 REF.Article

BIOLOGICAL ACTION OF THE LIPOTROPHIC PEPTIDES A AND B FROM PIG PITUITARY GLANDS = ACTION BIOLOGIQUE DES PEPTIDES LIPOTROPHIQUES A ET B D'HYPOPHYSES DE PORCWEISWEILER P; SCHWANDT P.1975; ACTA ENDOCRINOL.; DANEM.; DA. 1975; VOL. 79; NO 1; PP. 34-42; BIBL. 27 REF.Article

PREPARATION OF PORCINE NEUROPHYSIN PROTEINS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYRICHTER W; SCHWANDT P.1981; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1981; VOL. 36; NO 3; PP. 1279-1280; BIBL. 6 REF.Article

EFFECT OF BEZAFIBRATE ON THE HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS HDL2 AND HDL3 IN PRIMARY HYPERLIPOPROTEINEMIA TYPE IVSCHWANDT P; WEISWEILER P.1980; ARTERY; ISSN 0098-6127; USA; DA. 1980; VOL. 7; NO 6; PP. 464-470; BIBL. 14 REF.Article

  • Page / 7